AxoGen, Inc. AXGN announced the initiation of rolling submission of a Biologics License Application (BLA) seeking licensure for its human nerve allograft candidate, Avance Nerve Graft, to the FDA on ...
Beth Thiele remembers what her foot felt like after having her fourth foot surgery 2 1/2 years ago to try to fix damage caused by osteoarthritis. "It's like being electrocuted," she says. It was like ...
ALACHUA, Fla. and TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User ...
With top line results from its major phase III RECON study in hand, Axogen Inc. is hoping to expand adoption of its allograft nerve repair product Avance. RECON was designed as a non-inferiority study ...
Injury to the lateral femoral cutaneous nerve (Bernhardt's syndrome) or meralgia paresthetica occurs after harvest of the bone from the anterior iliac crest. The lateral femoral cutaneous nerve is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results